× Your unusual option activity trade stream may be delayed about 12 hours. Select a subscription plan to receive real-time data.

Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

UOA Trade History
Loading...


Minerva Neurosciences Bullish Option Trades

Minerva Neurosciences call option trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.



Loading...
Loading...

Minerva Neurosciences Bearish Option Trades

Minerva Neurosciences put option trades that are bought on or above the market's asking price OR call trades that are sold on or less than the market's bid price - expecting a move to the downside.



Loading...
Loading...